Retrospective Study
Copyright ©The Author(s) 2019.
World J Gastroenterol. Jan 7, 2019; 25(1): 107-117
Published online Jan 7, 2019. doi: 10.3748/wjg.v25.i1.107
Table 4 Urinary marker levels at enrollment between patients with severe and mild pancreatitis by computed tomography Grade according to the Japanese Ministry of Health, Labour and Welfare criteria (2008)[15]
Severity by CT Grade
SevereMild
No. cases2842
Score of CT Grade: mean (SD)2.37 (0.69)0.17 (0.38)
Extra-pancreatic progression of inflammation (Score 0/1/2)0/1/2735/7/0
Hypo-enhanced lesion of the pancreas (Score 0/1/2)19/3/442/0/0
Age: median (LQ, UQ), yr53 (44, 67)61 (47.5, 73.25)
Sex: male/female, n20/624/18
Median (LQ, UQ)AUC
Urinary trypsinogen-2, mg/dL14.68(2.10, 66.90)2.69(0.20, 17.11)0.701
Urinary trypsinogen-2/cre14.40(4.29, 104.03)6.36(0.32, 17.94)0.678
Urinary TAP, ng/mL3.98(2.20, 7.81)2.07(0.96, 3.87)0.692
Urinary TAP/cre, × 0.00016.70(4.15, 10.90)3.10(2.20, 6.00)0.727
Urinary amylase, × 1000 U/L1.94(0.64, 3.62)0.97(0.47, 2.29)0.615
Urinary amylase/cre, U/mg3.54(0.63, 5.88)2.23(0.88, 3.65)0.588
Urinary creatinine, × 10 mg/dL6.55(3.54, 9.24)5.54(3.49, 10.47)0.472
Serum amylase, × 100 U/L9.28(2.88, 15.22)6.28(3.91, 11.74)0.588
Serum lipase, × 100 U/L8.10(1.82, 18.49)6.95(4.32, 15.73)0.521
Serum creatinine, × 0.1 mg/dL7.25(5.40, 8.90)6.90(5.75, 7.95)0.574

  • Citation: Yasuda H, Kataoka K, Takeyama Y, Takeda K, Ito T, Mayumi T, Isaji S, Mine T, Kitagawa M, Kiriyama S, Sakagami J, Masamune A, Inui K, Hirano K, Akashi R, Yokoe M, Sogame Y, Okazaki K, Morioka C, Kihara Y, Kawa S, Tanaka M, Andoh A, Kimura W, Nishimori I, Furuse J, Yokota I, Shimosegawa T. Usefulness of urinary trypsinogen-2 and trypsinogen activation peptide in acute pancreatitis: A multicenter study in Japan. World J Gastroenterol 2019; 25(1): 107-117
  • URL: https://www.wjgnet.com/1007-9327/full/v25/i1/107.htm
  • DOI: https://dx.doi.org/10.3748/wjg.v25.i1.107